A Four-Way, Cross-Over Design, Randomized, Double-Blinded, Placebo-&Active-Controlled Study for the Evaluation of the Effect of a Supratherapeutic Dose of Sofpironium Bromide Gel, 15% Applied Topically on the QT/QTc Intervals in Adult Healthy Volunteers

Main Article Content

Brandon Kirsch
Danielle Armas
Deepak Chadha


Pharmacology, Anticholinergic, Sofpironium, Topical, QT, QTc


Abstract not available.


References not available.

Similar Articles

You may also start an advanced similarity search for this article.